Repligen Corporation
Repligen Corporation
http://www.repligen.com/ Researches, develops, manufactures and markets synthetic version of protein A for monoclonal antibody processing, and peptides such as secretin for gastrointestinal and pediatric neurology. Details for investors and clinical programs run from Waltham Massachusetts. (Nasdaq: RGEN) Biopharmaceuticals > Manufacturing Developing drugs that target novel biological pathways Products to enhance manufacturing efficiency and economics Repligen Reports Positive Phase 3 Clinical Trial Results for RG1068 in Pancreatic Imaging Repligen Reports Phase 2b Results for RG2417 for Bipolar Depression Repligen Reports ThirdFor detailed information visit the website, please... Repligen Home Page Repligen Corporation
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
Google Ads
Other links at Biopharmaceuticals > Manufacturing
1. Biolta Inc.
Privately owned company focusing on fermentation technologies, with production and recovery for cholesterol-lowering and alpha-glucosidase inhibitor drugs. Based in Calgary Alberta, Canada.
Category:
Development of cytokine analogs for cancer therapy, peptides for contraception, diagnosis and treatment of infertility. Includes introduction to technology, projects, key staff, and contacts for careers in Baesweiler, Germany.
Category:
Company developing small-molecule drugs and recombinant DNA proteins, which regulate gene activity and genetic processes in cancer and other diseases. Includes product information for patients and professionals from San Diego, California. (Nasdaq: LGND)
Category:
Main Category
14
100
31
5
50
7
11
40
166
20
59
76
24
75
110
142
7
8
13
30
66
Join Mailing List
Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.
Top 10
Directory Statistics
Links: 1054
Categories: 36
Pagerank Statistics
Yahoo News